US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

156.82

-2.5600-1.61%

Pre-market: 157.660.8400+0.54%08:16 EDT

Volume:9.71M

Turnover:1.52B

Market Cap:10.98B

PE:8.60

High:158.72

Open:157.59

Low:155.82

Close:159.38

52wk High:169.89

52wk Low:92.64

Shares:70.00M

Float Shares:70.00M

Volume Ratio:1.52

T/O Rate:13.87%

Dividend:0.56

Dividend Rate:0.36%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sector Update: Healthcare

MT Newswires Live

Mothers Facing Layoffs During Maternity Leave: It's Legal and More Common Than You Think

Worldwide Healthcare Trust Tightens Capital Base With Share Buyback

Health Care Roundup: Market Talk

HCA Healthcare's Reported Layoffs Consistent With Management's Resiliency Initiatives, RBC Says

MT Newswires Live

Definitive Healthcare Gets Acquisition Interest from Advent International

Definitive Healthcare confirms going-private proposal from Advent International

Why Is Purple Biotech (PPBT) Stock 42% Up Today?

Datametrex to Exit Healthcare Clinics and Double Down on AI and Patent Licensing

Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and Medtronic (MDT)

Definitive Healthcare CEO Kevin Coop departs, Clay Ritchey succeeds

Definitive Healthcare Appoints Clay Ritchey as CEO

Health Care Select Sector SPDR: Pivot points

Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference

Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference

Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference

Purple Biotech issued notice of allowance from USPTO

Analysts Offer Insights on NA Companies: SpaceX (SPCX) and HCA Healthcare (HCA)

Kane Biotech Expands Canadian Reach for revyve Wound Care via Ontario Medical Supply Deal

Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/XBI/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":156.82,"timestamp":1789070400000,"preClose":159.38,"halted":0,"volume":9708772,"hourTrading":{"tag":"盘前","latestPrice":157.66,"preClose":156.82,"latestTime":"08:16 EDT","volume":16266,"amount":2565407.80536,"timestamp":1789128998289,"change":0.84,"changeRate":0.005356,"amplitude":0.00689},"delay":0,"changeRate":-0.016062241184590303,"floatShares":70000000,"shares":70000000,"eps":18.23,"marketStatus":"Pre-Mkt","change":-2.56,"latestTime":"09-11 08:18:58 EDT","open":157.59,"high":158.72,"low":155.82,"amount":1524788759.19668,"amplitude":0.018196,"askPrice":157.78,"askSize":100,"bidPrice":157.5,"bidSize":274,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.82,"sharesOutstanding":63325000,"nav":159.388213,"aum":10738780848.695,"dividendRate":0.0036,"bidAskSpread":0.000341,"preHourTrading":{"tag":"盘前","latestPrice":157.66,"preClose":156.82,"latestTime":"08:16 EDT","volume":16266,"amount":2565407.80536,"timestamp":1789128998289,"change":0.84,"changeRate":0.005356,"amplitude":0.00689},"postHourTrading":{"tag":"盘后","latestPrice":156.6,"preClose":156.82,"latestTime":"19:58 EDT","volume":83781,"amount":13132833.9652,"timestamp":1789084712330,"change":-0.22,"changeRate":-0.001403,"amplitude":0.003061},"volumeRatio":1.5231930692292028,"impliedVol":0.3067,"impliedVolPercentile":0.456},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":70000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.5231930692292028,"shares":70000000,"dividePrice":0.5646,"high":158.72,"amplitude":0.018196,"preClose":159.38,"low":155.82,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.82,"committee":0.465241,"eps":18.23,"divideRate":0.0036,"volume":9708772,"delay":0,"ttmEps":18.23,"open":157.59,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":165.37,"twentyDayClose":159.39,"sixtyDayClose":136.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664117843","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:12","pubTimestamp":1788369173,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each adding about 0.8%.The iShares Biotechnology ETF  increased 0.6%.In corporate news, Johnson & Johnson  is positioned for accelerating growth, supported by a strong pharma pipeline, UBS said in a note. UBS assumed coverage of the stock with a buy rating and a $320 price target. Shares rose 1.5%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","IE00BDGV0183.EUR","IE00BGHQF631.EUR","PJP","BMED","IE0009355771.USD","IXJ","LU0689472784.USD","LU1629891620.HKD","LU1935042991.SGD","VHT","LU1228905037.USD","FTXH","SGXZ80539844.SGD","FHLC","LU2403377893.USD","JDOC","LU0795875086.SGD","LU1121112475.USD","IBB","XLV","LU0943347566.SGD","IE0001KFT4U8.USD","IE000MB6IJN5.SGD","HCSG","LU1506573853.SGD","IHE","RXL","LU2487616109.SGD","SG9999002224.SGD","LU0029874061.USD","MEDX","LU1032955483.USD","BK4532","IYH","LU1244550577.SGD","LU1718418525.SGD","LU2133065610.SGD","IE00BFXG1179.USD","JNJ","LABU","LU0122379950.USD","BK4534","SG9999013999.USD","LU0234572021.USD","LU0058720904.USD","LU2417539215.USD","TRUH","GDOC","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169327195","title":"Mothers Facing Layoffs During Maternity Leave: It's Legal and More Common Than You Think","url":"https://stock-news.laohu8.com/highlight/detail?id=1169327195","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169327195?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:00","pubTimestamp":1788368435,"startTime":"0","endTime":"0","summary":"Losing a job is never well-timed. Losing one while caring for a newborn is especially brutal. Jess Mayhew was sitting on her couch at home with her newborn son beside her when she received the call...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4223","DEI","BK4194","LABU","BK4588","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843990","title":"Worldwide Healthcare Trust Tightens Capital Base With Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843990","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843990?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:47","pubTimestamp":1788367644,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) just unveiled an announcement. Worldwide Healthcare Trust PLC, a specialist investment trust targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","XBI","LU0029874061.USD","BK4588","LABU","LU0128526141.USD","BK4581","XLV","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844843","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844843","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:20","pubTimestamp":1788366000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0621 ET - EssilorLuxottica remains on a strong track after a sol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","LABU","BK4585","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664084870","title":"HCA Healthcare's Reported Layoffs Consistent With Management's Resiliency Initiatives, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664084870","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664084870?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:16","pubTimestamp":1788365763,"startTime":"0","endTime":"0","summary":"HCA Healthcare's  reported job cuts are consistent with the enhanced resiliency initiatives that management has been indicating, RBC Capital Markets said in a note Tuesday.HCA confirmed the layoffs across corporate and support functions, citing ongoing shifts in healthcare policy, rising uninsured patient volumes, and cost pressures, RBC said.The investment bank adjusted its outlook to reflect greater resiliency benefits in Q4, as well as management's prior commentary pointing to more difficult year-over-year volume comparisons in Q3 and easier comparisons in Q4.RBC lowered its Q3 EBITDA estimate to $3.635 billion from $3.859 billion and raised its Q4 EBITDA estimate to $4.284 billion from $4.064 billion. Its full-year EBITDA estimate remains unchanged at $15.749 billion.RBC kept an outperform rating on HCA Healthcare with a price target of $435.Price: 411.30, Change: -2.28, Percent Change: -0.55","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2244417387.USD","LU0203347892.USD","LU0985489474.SGD","LABU","LU2355687059.USD","LU0433182093.SGD","BK4504","LU1119994496.HKD","LU0708994859.HKD","IHF","SG9999014039.USD","LU1267930490.SGD","XLV","SG9999014013.SGD","LU0868494617.USD","LU1084165304.USD","HCA","LU0980610538.SGD","BK4585","LU0128525929.USD","LU1201861249.SGD","LU0068578508.USD","IE00B3S45H60.SGD","LU0211328371.USD","LU0310800379.SGD","SG9999014005.SGD","LU1267930573.SGD","LU0648001328.SGD","LU1261432733.SGD","BK4185","LU1489326972.SGD","LU0130102774.USD","LU0882574055.USD","LU0211327993.USD","LU0203345920.USD","LU1150488135.SGD","XBI","LU0878866978.SGD","BK4588","SG9999014021.USD","LU0187121727.USD","LU0114720955.EUR","LU0310799852.SGD","LU0029864427.USD","LU1150488218.USD","BK4581","IE00B775SV38.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812985","title":"Definitive Healthcare Gets Acquisition Interest from Advent International","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812985","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812985?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:29","pubTimestamp":1788355740,"startTime":"0","endTime":"0","summary":"Definitive Healthcare said it has received a notice of interest from Advent International to acquire the company for $1.02 a share.Advent, a private-equity firm, would pay in all cash and would bring the healthcare market data provider private, per the non-binding letter.Shares of Definitive Healthcare jumped 14% to $1.03 in premarket trading.Definitive Healthcare said it has formed a special committee composed of independent directors to take actions with respect to a potential deal with Advent.The company doesn't plan to disclose any further updates about the deal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4167","XLV","DH","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812156","title":"Definitive Healthcare confirms going-private proposal from Advent International","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812156","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812156?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:25","pubTimestamp":1788355516,"startTime":"0","endTime":"0","summary":"The special committee of the board of directors of Definitive Healthcare (DH) announced that it has received a non-binding indication of interest f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-confirms-going-private-proposal-from-advent-international-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-confirms-going-private-proposal-from-advent-international-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","BK4167","LABU","DH","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812198","title":"Why Is Purple Biotech (PPBT) Stock 42% Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812198?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:22","pubTimestamp":1788355378,"startTime":"0","endTime":"0","summary":"Purple Biotech stock surged higher on Wednesday after the company announced a patent update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-purple-biotech-ppbt-stock-42-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-purple-biotech-ppbt-stock-42-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","PPBT","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664481233","title":"Datametrex to Exit Healthcare Clinics and Double Down on AI and Patent Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664481233","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664481233?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:13","pubTimestamp":1788354831,"startTime":"0","endTime":"0","summary":"Datametrex AI ( ($TSE:DM) ) has issued an announcement. Datametrex AI Limited has begun winding down its healthcare operations, including multi-dis...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/datametrex-to-exit-healthcare-clinics-and-double-down-on-ai-and-patent-licensing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/datametrex-to-exit-healthcare-clinics-and-double-down-on-ai-and-patent-licensing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4550","CHAT","XLV","BK4588","HCSG","BK4137","CGCV","LU0128526141.USD","LABU","AIPO","BK4585","VTHR","IXJ","VHT","TCAF","NOBL","QTOC","LU0029874061.USD","AGIX","XBI","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281410","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281410?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:50","pubTimestamp":1788353406,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on United Therapeutics (UTHR) and Medtronic (MDT). United Therapeuti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-united-therapeutics-uthr-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-united-therapeutics-uthr-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","LU1116320901.HKD","LU2271345857.HKD","UTHR","MDT","IE00BVYPNW00.USD","LU2023251221.USD","LU2089284900.SGD","LU0265550946.USD","LU0320765489.SGD","LU1057294990.SGD","LU0496365809.HKD","IE00BVYPNV92.GBP","BK4137","LU1506573853.SGD","BK4566","IE00B42XCP33.USD","LU0265550359.USD","LU0072461881.USD","IE00BQXX3F31.USD","XLV","LU0070302665.USD","LU0432979614.USD","IE00B3PB1722.GBP","IE00BQXX3D17.EUR","LU1291159041.SGD","LU1989764664.SGD","LU0211331839.USD","XBI","BK4532","BK4581","LU1244550221.USD","LU2468319806.SGD","LU0029874061.USD","LU0208291251.USD","BK4585","HCSG","BK4139","LU1244550494.USD","LABU","LU0976567544.SGD","LU2111349929.HKD","LU1989771016.USD","IE000M9KFDE8.USD","LU0211326755.USD","LU2028103732.USD","LU2089984988.USD","LU1244550577.SGD","LU1116320737.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814489","title":"Definitive Healthcare CEO Kevin Coop departs, Clay Ritchey succeeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814489","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814489?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:45","pubTimestamp":1788353109,"startTime":"0","endTime":"0","summary":"Definitive Healthcare (DH) announced that its board of directors has appointed Clay Ritchey as the company’s next CEO and as a member of the board ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-ceo-kevin-coop-departs-clay-ritchey-succeeds-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-ceo-kevin-coop-departs-clay-ritchey-succeeds-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DH","BK4588","XBI","XLV","LABU","BK4167","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664981121","title":"Definitive Healthcare Appoints Clay Ritchey as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664981121","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664981121?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"Mr. Ritchey brings more than 25 years of deep healthcare expertise to DefinitiveFRAMINGHAM, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355135/0/en/definitive-healthcare-appoints-clay-ritchey-as-ceo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","DH","IXJ","XBI","CGCV","TCAF","BK4550","BK4585","BK4581","XLV","BK4588","VHT","NOBL","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811085","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811085?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:25","pubTimestamp":1788351957,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.60, Pivot Low: $170.10. These were calculated usi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-135?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-135?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","XBI","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819046","title":"Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819046","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819046?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355075/0/en/acrivon-therapeutics-to-present-at-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","BK4588","LENZ","BK4139","XLV","LABU","BK4539","LU0029874061.USD","LU0128526141.USD","BK4585","HCSG","BK4581","BK4007","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819044","title":"Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819044","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819044?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355100/0/en/design-therapeutics-to-participate-in-2026-cantor-fitzgerald-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN","BK4581","LU0128526141.USD","BK4137","HCSG","BK4539","BK4139","LABU","XLV","BK4585","BK4505","XBI","BK4588","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664118518","title":"Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664118518","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664118518?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"GARDEN CITY, N.Y., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355096/0/en/beyond-air-to-participate-in-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","XBI","LU0128526141.USD","BK4585","BK4082","LABU","XLV","XAIR","BK4137","BK4588","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664462819","title":"Purple Biotech issued notice of allowance from USPTO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664462819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664462819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:50","pubTimestamp":1788349821,"startTime":"0","endTime":"0","summary":"Purple Biotech (PPBT) announced that the U.S. Patent and Trademark Office, or USPTO, has issued a notice of allowance for a patent application cove...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/purple-biotech-issued-notice-of-allowance-from-uspto-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/purple-biotech-issued-notice-of-allowance-from-uspto-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","BK4581","XBI","BK4588","BK4007","BK4585","PPBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819473","title":"Analysts Offer Insights on NA Companies: SpaceX (SPCX) and HCA Healthcare (HCA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819473?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:50","pubTimestamp":1788349806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on SpaceX (SPCX) and HCA Healthcare (HCA) with bullish sentimen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-spacex-spcx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-spacex-spcx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ELOL","XOVL","SPCX","SNK","MARS","SPCH","XLV","ORBX","XOVR","HCA","SG9999014013.SGD","LU0068578508.USD","LU0878866978.SGD","IHF","BK4504","LU1861220033.SGD","SPAL","SPCF","YSPC","LU1261432733.SGD","LU2290526834.HKD","BK4615","UFO","BK4089","DXYZ","LU0708994859.HKD","LOFF","LU1267930490.SGD","LU0130102774.USD","LU2244417387.USD","LU1489326972.SGD","NA","LU0980610538.SGD","SPAX","LU1150488218.USD","SPCQ","SPCU","LU2360107168.USD","SSPC","BK4588","LOFD","SPCG","XBI","SPCM","WSPC","WARP","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816778","title":"Kane Biotech Expands Canadian Reach for revyve Wound Care via Ontario Medical Supply Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816778?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:39","pubTimestamp":1788349189,"startTime":"0","endTime":"0","summary":"An announcement from Kane Biotech ( ($TSE:KNE) ) is now available. Kane Biotech has signed a non-exclusive distribution agreement with Ontario Medi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kane-biotech-expands-canadian-reach-for-revyve-wound-care-via-ontario-medical-supply-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kane-biotech-expands-canadian-reach-for-revyve-wound-care-via-ontario-medical-supply-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664554819","title":"Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664554819","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664554819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348600,"startTime":"0","endTime":"0","summary":"WAYNE, Pa., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commerciali","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355020/0/en/palvella-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","PVLA","XBI","LABU","XLV","LU0128526141.USD","HCSG","LU0029874061.USD","BK4585","BK4581","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":13,"totalSize":373,"code":"91000000","status":"200"}]}}